We are live on ! Find out more
ELEV

Elevation Oncology

Delisted

ELEV was delisted on the 22nd of July, 2025.

Name Holding Trade Value Shares
Change
Change in
Stake
ACM
1
Aisling Capital Management
New York
$22.1M
VP
2
venBio Partners
California
$20.3M
DCM
3
Driehaus Capital Management
Illinois
$15.6M -$21.1K -1,950 -0.1%
CAM
4
Cormorant Asset Management
Massachusetts
$15.1M
BI
5
BVF Inc
California
$12.4M +$76 +7 +0%
BC
6
Boxer Capital
California
$10.5M
Janus Henderson Group
7
Janus Henderson Group
$9.38M +$2.04M +188,517 +18%
SB
8
Samsara BioCapital
California
$7.26M +$11 +1 +0%
Vanguard Group
9
Vanguard Group
Pennsylvania
$5.11M +$6.44M +595,409 +992%
VC
10
Vivo Capital
California
$3.87M
CCM
11
CAAS Capital Management
New York
$467K
CC
12
Caxton Corporation
New Jersey
$375K +$93K +8,597 +22%
WP
13
Woodline Partners
California
$190K -$952K -88,066 -78%
BlackRock
14
BlackRock
New York
$186K +$258K +23,837 New
State Street
15
State Street
Massachusetts
$144K +$200K +18,500 New
SSA
16
Schonfeld Strategic Advisors
New York
$141K -$82.8K -7,656 -30%
WMSA
17
Weiss Multi-Strategy Advisers
New York
$112K -$6.87K -635 -4%
Geode Capital Management
18
Geode Capital Management
Massachusetts
$94K +$131K +12,156 New
Morgan Stanley
19
Morgan Stanley
New York
$12K +$17.1K +1,580 New
Osaic Holdings
20
Osaic Holdings
Arizona
$9K +$11.9K +1,100 New
SPIA
21
Steward Partners Investment Advisory
New York
$4K
MIM
22
Monashee Investment Management
Massachusetts
-$1.9M -140,000 Closed
Alyeska Investment Group
23
Alyeska Investment Group
Illinois
-$1.7M -125,000 Closed
PAMP
24
Polar Asset Management Partners
Ontario, Canada
-$1.7M -125,000 Closed
Millennium Management
25
Millennium Management
New York
-$1.67M -123,062 Closed